Jobs / United States / Sanofi US Services INC
Senior Director Type 2 Immunology
Sanofi US Services INC · 🇺🇸 Cambridge, MA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Sanofi US Services INC paid sponsored hires in similar roles1 certified filing for “Sr. Director Search & Evaluation, Immunology & Inflammation” (Natural Sciences Managers) in MA: $289k–$289k, median $289k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Sanofi US Services INC
The US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Sanofi US Services INC →
About the role
Job title: Senior Director Type 2 Immunology Location: Cambridge, MA About the job We have an exciting opportunity to join Sanofi's Type 2 Immunology cluster. This role sits at the intersection of cutting-edge preclinical research and clinical development, offering a unique platform to shape the trajectory of one of the industry's most compelling immunology portfolios. Working at our Cambridge Crossing research campus, you will contribute to a team with deep commitment to scientific excellence and patient impact across dermatology, gastroenterology, respiratory, and rheumatology. The Senior Director, Type 2 Immunology is a senior research leadership role responsible for driving scientific discovery, translational medicine, and research innovation within Sanofi's Type 2 Immunology portfolio. Reporting directly to the Senior Cluster Head, Type 2 Immunology, this individual will lead cutting edge research programs, identify and validate novel therapeutic targets, and oversee the translation of scientific insights into clinical development strategies. This role serves as a principal scientific authority in the Type 2 inflammatory disease and will be instrumental in shaping Sanofi's long term research vision in this space, and beyond. The successful candidate will leverage Sanofi's extensive technical capabilities, including AI enabled platforms, single cell technologies, and multiomic approaches, while collaborating closely with Development, Medical Affairs, and Commercial teams. This is an opportunity to make a meaningful scientific and strategic contribution within a highly collaborative, cross functional environment. Join the engine of Sanofi’s mission — where deep immunoscience meets bold, AI-powered research. In R&D, you’ll drive breakthroughs that could turn the impossible into possible for millions. About Sanofi We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives. Main Responsibilities: • Execute and refine the Type 2 Immunology research strategy, identifying novel biological targets and therapeutic hypotheses to advance the pipeline. • Drive long range research planning, portfolio prioritization, and investment decisions across preclinical and translational programs. • Monitor and integrate emerging scientific advances, competitive intelligence, and unmet medical needs to continuously evolve the research agenda. • Represent Type 2 Immunology research in senior leadership forums, governance committees, and pipeline review boards. • Oversee preclinical and translational research programs, from target identification and validation through to candidate nomination. • Lead mechanism of action studies and disease biology investigations to deepen understanding of Type 2 inflammatory pathways in both preclinical and translational settings. • Drive biomarker identification, development, and qualification strategies to support patient stratification, proof of concept, and clinical decision making. • Ensure scientific rigor and innovation across all stages of the drug discovery and development continuum. • Support our development and medical colleagues in championing investigator initiated studies and collaborative research programs that generate mechanistic and clinical insights. • Partner with Clinical Development and Regulatory Affairs to translate preclinical findings into clinical hypotheses and study designs. • Oversee the scientific interpretation of clinical data to inform pipeline progression and lif